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Synopsis 
The structure of a cisplatin-modified DNA dodecamer duplex containing a 1,2-cis-
{Pt(NH3)2}2+-d(GpG) cross-link has been determined at 1.77-Å resolution. Improved 
electron density reveals new features not seen in the originally published 2.6 Å 
structure. 
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Abstract 
 We report the 1.77-Å resolution X-ray crystal structure of a dodecamer DNA 
duplex with the sequence 5'-CCTCTGGTCTCC-3' that has been modified to contained 
a single engineered 1,2-cis-{Pt(NH3)2}2+-d(GpG) cross-link, the major DNA adduct of 
cisplatin. These data represent a significant improvement in resolution over the 
previously published 2.6-Å structure. The ammine ligands in this structure are clearly 
resolved, leading to improved geometry of the cross-link. Other new features of this 
model include the location of four octahedral [Mg(H2O)6]2+ complexes associated with 
bases in the DNA major groove and the identification of 124 additional ordered water 
molecules that participate in hydrogen bonding interactions with either the nucleic acid 
or the diammineplatinum(II) moiety. The global DNA geometry is overall very similar 
between the current and originally determined structures. 
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1. Introduction 
 Platinum-based therapy remains a highly utilized and effective option in the 
treatment of many types of cancer [1]. After cisplatin (cis-diamminedichloroplatinum(II)) 
was discovered to have antitumor properties more than 40 years ago [2, 3], much 
research has focused on unraveling the mode of action of this compound. Nuclear DNA 
is a molecular target for platinum anticancer compounds, which bind purine bases at the 
N7 position. The resulting Pt-DNA damage triggers downstream effects including 
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inhibition of replication and transcription, cell cycle arrest, and attempted repair of the 
damaged nucleotides. If the cell cannot remove the damage then it dies by one of 
several pathways [4]. 
 Revealing the structural details of Pt-DNA adducts represented a significant 
milestone in platinum anticancer research. This information has helped to build 
structure-activity relationships that underlie transcription inhibition and cell death. The 
major adduct of cisplatin-DNA binding is a 1,2-intrastrand adduct between adjacent 
guanine bases; a minor percentage of 1,3-intrastrand and interstrand cross-links also 
form [4]. The 1,2-d(GpG) cisplatin cross-link was first characterized crystallographically 
in a DNA dodecamer duplex in 1996 at 2.6-Å resolution. This structure revealed that the 
Pt adduct induces a global bend of 35-40° in the DNA duplex and unwinds the double 
helix by ~25° [5, 6]. The major groove is compacted and the minor groove widened and 
flattened. A-form DNA comprises the nucleic acid to the 5’ side of the Pt cross-link, and 
B-DNA forms to the 3’ side of the 1,2-d(GpG) adduct. The roll angle between platinated 
guanine bases is 26° and, as a consequence, results in considerable strain being 
placed on the Pt-N7 bonds, displacing the Pt atom out of the guanine ring planes by 
approximately 1 Å each. 
 In the present article we report a higher resolution, 1.77 Å structure of this 
complex, a dodecamer duplex having the sequence 5'-CCTCTG*G*TCTCC-3', where 
the asterisks denote platination sites. This significant increase in resolution offers a 
much-improved view of the molecule, especially in the Pt-DNA adduct region. Pt–N 
bond distances and angles for the present model now match closely the values 
expected for a square-planar Pt coordination compound. Also located in the current 
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structure are four octahedral [Mg(H2O)6]2+ complexes that interact with the DNA duplex 
through the primary hydration sphere, and ordered water molecules that hydrogen bond 
to both the nucleic acid and the {Pt(NH3)2}2+ unit. The global DNA geometry remains 
relatively unchanged compared to that of the original structure. These new, high 
resolution results reveal valuable structural features of the cisplatin 1,2-cis-{Pt(NH3)2}2+-
d(GpG) cross-link on DNA not previously attainable. 
 
2. Materials and Methods 
 Phosphoramidites, columns, and other reagents for solid-phase oligonucleotide 
synthesis were purchased from Glen Research. Potassium tetrachloroplatinate(II), 
which was used to synthesize cisplatin according to published procedures [7], was a gift 
from Engelhard (Iselin, NJ, now BASF). Crystallization reagents and supplies were 
obtained from Hampton Research. All other reagents were purchased from commercial 
suppliers and used without further purification. Oligonucleotides were prepared in-house 
using an Applied Biosystems Model 392 DNA/RNA Synthesizer. Liquid chromatography 
was performed with an Agilent 1200 series HPLC equipped with a temperature-
controlled autosampler and automated fraction collector. Atomic absorption 
spectroscopy was performed with a Perkin Elmer AAnalyst 300 system. UV-Vis spectra 
were collected on a Hewlett-Packard 8453 spectrophotometer. 
 
2.1. Preparation of platinated DNA duplex 
 The oligonucleotide 5’-d(CCTCTGGTCTCC)-3’ (1) and its complement (2) were 
synthesized on a 2x1.0 µmol scale with dimethoxytrityl (DMT) groups on by standard 
 4 
solid-phase synthetic methods. The strands were purified by reversed-phase high-
pressure liquid chromatography (HPLC) on an Agilent SB-300, 9.4 x 250 mm column, 
with a linear gradient of 100 mM triethylammonium acetate pH 7.0 and acetonitrile. After 
lyophilization of combined fractions, DMT groups were removed in 80% acetic acid for 
30 min at room temperature, and the oligonucleotides were precipitated with 
isopropanol and desalted with Waters Sep-Pak C18 cartridges. Reaction of 1 with 1.2 
equiv of cisplatin was carried out in 10 mM HEPES pH 6.8 buffer for 14 h at 37 °C. 
Platinated product was purified by ion-exchange HPLC on a Dionex DNA-Pac PA-100, 
9.4 x 250 mm column at 35 °C, with a mobile phase of 90:10 25 mM Na acetate pH 
5.2:acetonitrile and a linear NaCl gradient. Combined peak fractions were dialyzed 
against water overnight, then lyophilized and reconstituted in water, yielding 5’-
d(CCTCTG*G*TCTCC)-3’ (3). The site-specifically platinated duplex was prepared by 
combining equimolar amounts of 3 and 2 in 200 µL of 200 mM LiCl, 100 mM HEPES pH 
7.0, and 50 mM MgCl2, heating to 70 °C for 10 min, and cooling to 4 °C over 2.5 h. The 
duplex was purified by ion exchange HPLC as described above but with a LiCl gradient. 
The final product was dialyzed, lyophilized, and desalted as described above.  
 
2.2 Crystallization and X-ray diffraction data collection 
 Diffraction-quality crystals were grown by hanging-drop vapor diffusion at 4 °C. 
Crystallization solutions contained 120 mM magnesium acetate, 50 mM sodium 
cacodylate pH 6.5, 1 mM spermine, and 28% w/v polyethylene glycol (PEG) 4000; 
hanging drops contained 2 µL of 0.4 mM Pt-DNA in water and 2 µL of crystallization 
solution, equilibrated against 1 mL of crystallization solution. All solutions were prepared 
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and sterile filtered immediately before use. Crystals with dimensions of ~1.0 mm x 0.2 
mm x 0.1 mm grew in clusters in approximately two weeks. 
 Single crystals were isolated from the clusters and transferred to a cryoprotectant 
solution of 120 mM magnesium acetate, 50 mM sodium cacodylate pH 6.5, 1 mM 
spermine, 28% w/v polyethylene glycol (PEG) 4000, and 15% v/v glycerol, mounted on 
loops, and flash frozen directly in liquid nitrogen. Diffraction data were collected at 100 
K (λ = 0.979 Å) at beamline 9-2 of the Stanford Synchrotron Radiation Laboratory 
(SSRL), and processed in HKL2000 [8]. Data were collected over 360° with 1° 
oscillation per frame. Data collection statistics are shown in Table 1. 
 
2.3. Structure determination 
 Phasing of the diffraction data was achieved by molecular replacement with the 
program Phaser [9] using the original structure (1AIO) with all water molecules removed 
as a search model. After one round of refinement with Refmac5 [10], the Rfree value was 
below 24%. Platinum-nitrogen bond distances and angles were adjusted to fit the 
improved electron density around the ammine ligands, and [Mg(H2O)6]2+ sites were 
inserted manually into the 2Fo-Fc and Fo-Fc electron density maps with the program 
Coot [11]. Water molecules were placed automatically with Coot into areas of Fo-Fc 
density above 3.5σ and then adjusted manually. Subsequent rounds of refinement and 
model adjustment were performed to afford the final model with an Rfree value of 20.9%. 
Final refinement statistics are given in Table 1. Nucleic acid geometric parameters were 
calculated with the program 3DNA [12]. Single point energy calculations were 
performed with Gaussian 03 suite of programs [13]. From the experimental structures, 
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the atomic valences were completed with hydrogen atoms. Thus, the final model carries 
a molecular charge of 2+. In this approach, the models are treated by Density 
Functional Theory (DFT), with the B3LYP functional [14, 15] and the 6-31g(d,p) basis 
set [16] on all light atoms (H, C, N, O and P). Platinum was represented by the Los 
Alamos LANL2DZ basis [17, 18], which includes relativistic effective core potentials. All 
crystallographic images in this paper were created using Pymol [19]. Coordinates have 
been deposited into the Protein Data Bank (PDB) with accession code XXXX. 
 
3. Results and discussion 
3.1 Unit cell and crystal packing 
 Crystals of the Pt-DNA construct were grown under different conditions than 
those reported from the original investigation; however, the two structures are nearly 
identical. The present conditions were used to obtain diffraction quality crystals of DNA 
duplexes containing an oxaliplatin-DNA cross-link [20] as well as a monofunctional Pt-
DNA adduct of cis-diammine(pyridine)chloroplatinum(II) [21]. Despite the difference in 
the present and previous conditions used to grow crystals, the cisplatin-modified duplex 
DNA crystallizes in the same space group, P1, and with nearly identical until cell 
dimensions as the previous structure. Unit cell dimensions for the original crystal 
structure are a = 31.27 Å, b = 35.46 Å, c = 47.01 Å, α = 79.81°, β = 84.75°, and γ = 
82.79°, whereas the dimensions for this crystal are a = 31.30 Å, b = 35.43 Å, c = 45.13 
Å, α = 80.06°, β = 84.09°, and γ = 81.77°, giving unit cell volumes of 50,770 Å3 and 
48,729 Å3, respectively. The 4% decrease in volume can be attributed to differences in 
temperature; data for the first cisplatin-DNA structure were collected at 277 K, whereas 
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we collected the current data at 100 K. Because the unit cells are nearly equivalent, 
packing interactions between molecules are also conserved between structures. Two 
unique DNA duplexes comprise the asymmetric unit that are related by non-
crystallographic symmetry and interact via hydrogen bonding, end-to-end, and end-to-
groove contacts in the crystal lattice. The combination of the latter two interactions in 
the same crystal is unusual, the former being typically observed in B-form DNA 
structures and the latter in crystals of A-form nucleic acids. As a possible consequence 
of these packing interactions, this cisplatin-modified DNA structure displays a unique 
characteristic that is absent in other structural studies of the 1,2-cis-{Pt(NH3)2}2+-d(GpG) 
cross-link in double stranded DNA, namely, considerable angular strain at the Pt–N7 
bonds. As a consequence, the platinum atom lies out-of-plane of the guanine bases by 
~1 Å each. This feature was noted in the original structure but was not analyzed in 
detail. Our high-resolution data confirm its presence in the structure and facilitates a 
thorough examination of its origin (vide infra). 
 
3.2. Global DNA geometry  
 Notable characteristics of DNA containing the cisplatin 1,2-{Pt(NH3)2}2+-d(GpG) 
cross-link, determined from the original crystal structure, include bending of the double 
helix by 35-40° toward the major groove and local duplex unwinding of ~25°. The roll 
angle between Pt-bound guanine bases is 26°, and the DNA takes on A-form properties 
on the 5' side of the Pt-DNA adduct, and B-form structure on the 3'-end [6]. However, 
the resolution limit prohibited direct visualization of deoxyribose sugar puckers, so ring 
conformations were indirectly determined by measuring distances between adjacent 
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phosphate atoms and examining base-stacking patterns. The same structural features 
are present in the current 1.77 Å structure (see Figs. 1a and S1), but the sugar ring 
conformations can be differentiated as either C2' endo (typical of A-form DNA) or C3' 
endo (for B-form DNA) by visualization of the electron density. DNAs from the previous 
and current models align nearly identically, with a root-mean-square deviation (rmsd) 
over all atoms of 0.472 Å (see Fig. 2). Although there are two molecules in the unit cell, 
the DNA structures of each are also equivalent, with a rmsd over all atoms of 0.18 Å. A 
detailed analysis of the global DNA structure will not be discussed here; it can be found 
in the original publication [6]. 
 
3.3. Pt adduct geometry 
 Unlike the overall DNA structure that is unchanged by addition of higher 
resolution diffraction data, the cisplatin adduct is significantly altered in the current 
model. Clear electron density is now visible for the ammine ligands of the 1,2-cis-
{Pt(NH3)2}2+-d(GpG) cross-link (see Fig. 1b), allowing the square-planar Pt geometry to 
be accurately evaluated. The Pt–N bond lengths for all four ligands average to 2.02 Å in 
the new model, compared to 1.90 Å in the previous structure, and 2.02 Å in the X-ray 
crystal structure of the 1,2-cis-{Pt(NH3)2}2+-d(GpG) dinucleotide determined at atomic 
resolution [22]. The average cis N–Pt–N angles for the current and prior models and the 
dinucleotide structure are 90.0°, 88.0°, and 90.0° respectively, with ranges of 83.9° - 
99.8°, 70.9° - 99.9°, and 86.9° - 94.3°, respectively. The trans angles are dramatically 
improved in the high-resolution model, with an average N–Pt–N value of 174.5°, 
compared to 156.9° in the 2.6 Å-resolution model and 175.1° for the isolated Pt-d(GpG) 
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cross-link. Thus the current model depicts a platinum adduct geometry that very nearly 
matches that observed in the X-ray crystal structure of the 1,2-cis-{Pt(NH3)2}2+-d(GpG) 
dinucleotide. A full comparison of Pt geometries is provided in Table 2.  
 Consistent with the original model, the platinum atoms are displaced from the 
guanine base planes. The metal atom lies out-of-plane of the 5' guanine by 1.2 and 1.1 
Å in the two molecules, and of the 3' nucleobase by 1.0 Å in both DNA duplexes. This 
feature, however, is inconsistent with data from both the X-ray crystal structure of the 
1,2-cis-{Pt(NH3)2}2+-d(GpG) dinucleotide [22] and the NMR solution structure of duplex 
DNA containing the lesion [23], in which the Pt atom is located within the guanine base 
planes and the dihedral angle between bases is ~90° (see Fig. 3). The shallow roll 
angle in the present X-ray crystal structure causes significant angular strain on the Pt–
N7 bonds. Single point energy calculations indicate that the {Pt(NH3)2}2+-d(GpG) moiety 
in the Pt-DNA X-ray structure is 14.6 kcal/mol higher in energy than the analogous NMR 
solution structure [23]. DNA end-to-end packing on the 3' side of the Pt adduct and end-
to-groove packing on the 5' side of the cross-link appear to dictate the global curve of 
the molecule and prevent complete opening of the guanine-guanine base pair roll angle. 
However, the same crystal packing contacts are capable of stabilizing the altered higher 
energy conformation, since a single hydrogen bonding interaction can contribute ca. 1 - 
9 kcal/mol in energy [24]. These results underscore the importance of evaluating 
macromolecular structures by multiple means, including NMR spectroscopy and 
biochemical methods in addition to X-ray crystallography, because each has its 
limitations. 
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3.4. Magnesium sites identified 
 Four fully aquated magnesium(II) cations were located in the major groove on the 
A-form side of the nucleic acid double helix. As in other DNA crystal structures, 
interaction of the Mg(aq)2+ cation and the DNA major groove occurs via hydrogen 
bonding, the water ligands serving as hydrogen bond donors to the N7 atoms of 
guanine and adenine bases and to the O6 atom of guanine (see Fig. 1c) [25, 26]. In all 
cases the [Mg(H2O)6]2+ cations interact with adjacent purine bases, either the terminal 
d(GpG) or the d(ApG) dinucleotide sequence at the 3' end of the unplatinated strand 
(see Fig. 4).  
 Significantly better electron density exists for two Mg(aq)2+ complexes bound to 
the terminal d(GpG) sequence than the other two sites. Crystallographic B-factors for 
the former are 39.1 and 38.1 Å2, compared to 53.4 and 49.2 Å2 for the latter. The 
d(GpG)-bound [Mg(H2O)6]2+ complexes contribute four hydrogen bonding interactions 
with the DNA bases, whereas the less ordered sites participate in only three such 
contacts. This difference is one possible reason why the first two sites have lower B-
factors. As a result, the Mg–OH2 bond distances for the former, which average 2.05 ± 
0.08 Å, are close to the reported literature values of 2.06 Å [26], and the complexes 
have nearly ideal octahedral symmetry. The magnesium(II) complexes that bind d(ApG) 
sequences near the platinum adduct, bases 20-21 and 44-45 as depicted in Fig. 5, 
have Mg–OH2 bond distances as long as 2.46 Å if left unrestrained (data not shown), 
which is clearly unrealistic and an artifact of insufficiently well defined electron density 
around those water ligands. These complexes were therefore refined with restraints on 
bond distances and angles, whereas the d(GpG) coordinated Mg(aq)2+ sites were 
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refined without restraints. No [Mg(H2O)]2+-DNA interactions were observed at the B-form 
end of this palindromic sequence, although they are probably present but not visible in 
the electron density. Average crystallographic B-factors for the four terminal base pairs 
on the 5' side of the Pt cross-link, where Mg(aq)2+ coordination is resolved, are 33.4 and 
34.6 Å2 for the two DNA duplexes. In contrast, these values are 44.4 and 44.5 Å2 for the 
last four base pairs on the 3' ends of the two molecules, indicating that the B-form 
sections of each nucleic acid are less ordered than the respective A-DNA segments.  
 
3.5. Ordered water molecules 
 Of the 148 ordered water molecules located in the model, 24 are bound to 
magnesium in an octahedral geometry as described above. The remaining 124 solvent 
molecules interact with either the platinum adduct, phosphodiester backbone, or the 
DNA bases. A schematic depiction of each of these solvent-DNA interactions is given in 
Fig. 5, and a full list of water contacts appears in Table S1. One water molecule 
participates in bridging hydrogen-bonding interactions with each of the platinum ammine 
ligands. Molecule A has four solvent molecules bound to the Pt-DNA adduct, whereas 
molecule B has only two ammine-bound waters. Unlike another high-resolution structure 
of Pt-modified DNA, no direct interaction between ordered waters and the platinum 
atom is observed [27, 28]. 
 Hydrogen bonding interactions between water molecules and nucleobases occur 
primarily at guanine N7, O6, or N3 atoms, adenine N7, N6, or N3, thymine O2 or O4, 
and cytosine N4 or O2 positions, consistent with previous observations of Watson-Crick 
base pair hydration patterns [29, 30]. Water contacts with oxygen atoms of the 
 12 
deoxyribose rings (O3', O4', or O5') are also observed, although less regularly. There 
are more resolved water-nucleobase interactions at the central base pairs in the 
duplexes; terminal base pairs do not show as much detail in the hydration sphere, 
presumably due to increased thermal motion. 
 The phosphodiester backbone of each DNA double helix is extensively hydrated, 
with water molecules participating in hydrogen bonding with the phosphate oxygen 
atoms. Mono- and bidentate interactions, either with two oxygen atoms from a single 
phosphate or from adjacent nucleotides, occur. Most bridging interactions between two 
phosphates are found in the central four base pairs, where the DNA backbone structure 
is distorted by the cisplatin cross-link. Some of the atoms modeled here as oxygen from 
water may actually be sodium ions, given that 50 mM sodium cacodylate was present in 
the crystallization buffer and that DNA exists as a polyanion and must be neutralized by 
cations. However, these two species cannot be differentiated by X-ray crystallography 
since Na+ and O2- each contain ten electrons; therefore, all non-magnesium solvent 
molecules were modeled as water. 
 
4. Conclusions 
 The structure of a dodecamer DNA duplex containing a centrally located 1,2-cis-
{Pt(NH3)2}2+-d(GpG) intrastrand cross-link of cisplatin was determined by X-ray 
crystallography to 1.77 Å resolution, a greater than 0.8 Å improvement over the 
previous structure solved in 1996. The improvement in resolution allowed us to model 
accurately the structure of the platinum adduct, which now closely matches its 
anticipated square-planar geometry, as well as to discover octahedral magnesium sites 
 13 
at multiple locations in the DNA major groove. Hydrogen bonding interactions from 148 
solvent water molecules were resolved here, compared with only 31 in the original 
structure.  
 Understanding the structural changes to DNA that occur upon binding of platinum 
antitumor agents is a critical step in deciphering the mechanism of these compounds. X-
ray crystallography is a powerful technique for answering some of these questions, and 
should continue to be relied upon in the future as other platinum complexes are 
synthesized and studied. From these data we can better understand how Pt-DNA 
adducts might be repaired and inhibit cellular transcription. Understanding these two 
functions is key to the design of improved platinum candidates for cancer 
chemotherapy.  
 
Acknowledgements 
This work was supported by the National Cancer Institute (grant CA034992 to SJL). 
RCT is grateful for a Koch Fund fellowship from the Koch Institute for Integrative Cancer 
Research at MIT. We thank Engelhard Corporation (now BASF) for the generous 
donation of K2PtCl4 used in this research and Juliana Fedoce Lopes for conducting 
single point energy calculations. Portions of this research were carried out at the 
Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford 
University on behalf of the U.S. Department of Energy, Office of Basic Energy Sciences. 
The SSRL Structural Molecular Biology Program is supported by the Department of 
Energy, Office of Biological and Environmental Research, and by the National Institutes 
 14 
of Health, National Center for Research Resources, Biomedical Technology Program, 
and the National Institute of General Medical Sciences. 
 
References 
[1] L. Kelland, Nat. Rev. Cancer 7 (2007) 573-584. 
[2] B. Rosenberg, L. Van Camp, T. Krigas, Nature 205 (1965) 698-699. 
[3] B. Rosenberg, L. Van Camp, J.E. Trosko, V.H. Mansour, Nature 222 (1969) 385-
386. 
[4] D. Wang, S.J. Lippard, Nat. Rev. Drug Discovery 4 (2005) 307-320. 
[5] P.M. Takahara, A.C. Rosenzweig, C.A. Frederick, S.J. Lippard, Nature 377 (1995) 
649-652. 
[6] P.M. Takahara, C.A. Frederick, S.J. Lippard, J. Am. Chem. Soc. 118 (1996) 12309-
12321. 
[7] S.C. Dhara, Indian J. Chem. 8 (1970) 193-194. 
[8] Z. Otwinowski, W. Minor, Methods Enzymol. 276 (1997) 307-326. 
[9] A.J. McCoy, R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, R.J. 
Read, J. Appl. Cryst. 40 (2007) 658-674. 
[10] G.N. Murshudov, A.A. Vagin, E.J. Dodson, Acta Crystallogr. D53 (1997) 240-255. 
[11] P. Emsley, K. Cowtan, Acta Crystallogr. D60 (2004) 2126-2132. 
[12] X.-J. Lu, W.K. Olson, Nucleic Acids Res. 31 (2003) 5108-5121. 
[13] M.J. Frisch, H.B.S. G. W. Trucks, G. E. Scuseria,, J.R.C. M. A. Robb, J. A. 
Montgomery, Jr., T. Vreven,, J.C.B. K. N. Kudin, J. M. Millam, S. S. Iyengar, J. Tomasi,, 
B.M. V. Barone, M. Cossi, G. Scalmani, N. Rega,, H.N. G. A. Petersson, M. Hada, M. 
Ehara, K. Toyota,, J.H. R. Fukuda, M. Ishida, T. Nakajima, Y. Honda, O. Kitao,, M.K. H. 
Nakai, X. Li, J. E. Knox, H. P. Hratchian, J. B. Cross,, C.A. V. Bakken, J. Jaramillo, R. 
Gomperts, R. E. Stratmann,, A.J.A. O. Yazyev, R. Cammi, C. Pomelli, J. W. Ochterski,, 
K.M. P. Y. Ayala, G. A. Voth, P. Salvador, J. J. Dannenberg,, S.D. V. G. Zakrzewski, A. 
D. Daniels, M. C. Strain,, D.K.M. O. Farkas, A. D. Rabuck, K. Raghavachari,, J.V.O. J. 
B. Foresman, Q. Cui, A. G. Baboul, S. Clifford,, B.B.S. J. Cioslowski, G. Liu, A. 
Liashenko, P. Piskorz,, R.L.M. I. Komaromi, D. J. Fox, T. Keith, M. A. Al-Laham,, A.N. 
C. Y. Peng, M. Challacombe, P. M. W. Gill,, W.C. B. Johnson, M. W. Wong, C. 
Gonzalez, and J. A. Pople, Gaussian, Inc. Wallingford CT (2004). 
 15 
[14] C. Lee, W. Yang, R.G. Parr, Phys. Rev. B 37 (1988) 785-789. 
[15] A.D. Becke, J. Chem. Phys. 98 (1993) 5648-5652. 
[16] W.J. Hehre, R. Ditchfield, J.A. Pople, J. Chem. Phys. 56 (1972) 2257-2261. 
[17] P.J. Hay, W.R. Wadt, J. Chem. Phys. 82 (1985) 299-310. 
[18] P.J. Hay, W.R. Wadt, J. Chem. Phys. 82 (1985) 270-283. 
[19] W.L. DeLano, DeLano Scientific, Palo Alto, CA, USA (2002). 
[20] B. Spingler, D.A. Whittington, S.J. Lippard, Inorg. Chem. 40 (2001) 5596-5602. 
[21] K.S. Lovejoy, R.C. Todd, S. Zhang, M.S. McCormick, J.A. D'Aquino, J.T. Reardon, 
A. Sancar, K.M. Giacomini, S.J. Lippard, Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 8902-
8907. 
[22] S.E. Sherman, D. Gibson, A.H.J. Wang, S.J. Lippard, J. Am. Chem. Soc. 110 
(1988) 7368-7381. 
[23] L.G. Marzilli, J.S. Saad, Z. Kuklenyik, K.A. Keating, Y. Xu, J. Am. Chem. Soc. 123 
(2001) 2764-2770. 
[24] D. Bandyopadhyay, D. Bhattacharyya, Biopolymers 83 (2006) 313-325. 
[25] M. Soler-López, L. Malinina, J.A. Subirana, J. Biol. Chem. 275 (2000) 23034-
23044. 
[26] J.A. Subirana, M. Soler-Lopez, Ann. Rev. Biophys. Biomol. Struct. 32 (2003) 27-45. 
[27] F. Coste, J.-M. Malinge, L. Serre, W. Shepard, M. Roth, M. Leng, C. Zelwer, 
Nucleic Acids Res. 27 (1999) 1837-1846. 
[28] F. Coste, W. Shepard, C. Zelwer, Acta Crystallogr. D58 (2001) 431-440. 
[29] B. Schneider, D.M. Cohen, L. Schleifer, A.R. Srinivasan, W.K. Olson, H.M. Berman, 
Biophys. J. 65 (1993) 2291-2303. 
[30] H.M. Berman, Biopolymers 44 (1997) 23-44. 
 
 
 
 
Figure Captions 
Figure 1. Structural features of cisplatin-damaged DNA. (a) Overall structure of duplex 
DNA containing a cisplatin cross-link (shown in white/gray). (b) Stereo images of the 
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platinum-bound base pairs in molecule A with 2Fo-Fc electron density (green around the 
DNA/blue around the Pt adduct) contoured at 1.5σ. (c) Stereo images of a [Mg(H2O)6]2+ 
octahedral site bound in the major groove of molecule A at guanine residues 23 and 24, 
with 2Fo-Fc electron density (shown in blue) contoured at 1.5σ. 
 
Figure 2. Stereo view of molecule A of the previously published structure of DNA 
modified with a 1,2-cis-{Pt(NH3)2}2+-d(GpG) cross-link (PDB accession code 1AIO, 
shown in blue) superimposed on the current high-resolution structure (XXXX, in red). 
The two molecules align almost identically, with a rmsd over all atoms of 0.472 Å. 
 
Figure 3. Views of the 1,2-cis-{Pt(NH3)2}2+-d(GpG) adduct as depicted by (a) the X-ray 
crystal structure of the isolated dinucleotide [22], (b) the NMR solution structure of the 
Pt moiety in 8-mer duplex DNA [23], and (c) the X-ray crystal structure determination of 
dodecamer DNA presented here. 
 
Figure 4. Binding of [Mg(H2O)6]2+ cations to purine dinucleotides in the cisplatin-DNA 
dodecamer duplex. Hydrogen bonding interactions between water ligands and 
nucleobases are depicted in cyan. 
 
Figure 5. Schematic depicting hydrogen-bonding interactions between solvent 
molecules and Pt-DNA. For clarity, many contacts between water molecules are 
omitted. 
 
